Patel Sushil (CIK 1860609) reported 18 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-07-01). Recent activity: Sell RVMD (600 shares), Sell RVMD (300 shares), Sell RVMD (900 shares), Sell RVMD (1,100 shares), Sell RVMD (858 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-01 | Revolution Medicines, Inc. (RVMD) | Director | Sell | 600 | $114,327 |
| 2026-07-01 | Revolution Medicines, Inc. (RVMD) | Director | Sell | 300 | $54,952 |
| 2026-07-01 | Revolution Medicines, Inc. (RVMD) | Director | Sell | 900 | $166,128 |
| 2026-07-01 | Revolution Medicines, Inc. (RVMD) | Director | Sell | 1,100 | $204,489 |
| 2026-07-01 | Revolution Medicines, Inc. (RVMD) | Director | Sell | 858 | $160,374 |
| 2026-07-01 | Revolution Medicines, Inc. (RVMD) | Director | Sell | 300 | $56,348 |
| 2026-07-01 | Revolution Medicines, Inc. (RVMD) | Director | Sell | 100 | $18,857 |
| 2026-07-01 | Revolution Medicines, Inc. (RVMD) | Director | Buy | 2,955 | $110,931 |
| 2026-07-01 | Revolution Medicines, Inc. (RVMD) | Director | Sell | 541 | $103,800 |
| 2026-07-01 | Revolution Medicines, Inc. (RVMD) | Director | Sell | 881 | $169,693 |
| 2026-06-23 | Revolution Medicines, Inc. (RVMD) | Director | Buy | 1,191 | $0 |
| 2026-05-20 | Replimune Group, Inc. (REPL) | Chief Executive Officer | Sell | 37,324 | $189,606 |
| 2026-04-07 | Replimune Group, Inc. (REPL) | Chief Executive Officer | Buy | 251,240 | $0 |
| 2025-12-19 | Replimune Group, Inc. (REPL) | Chief Executive Officer | Buy | 200,000 | $0 |
| 2025-12-04 | Replimune Group, Inc. (REPL) | Chief Executive Officer | Sell | 10,000 | $111,300 |
| 2025-06-30 | Revolution Medicines, Inc. (RVMD) | Director | Buy | 3,142 | $0 |
| 2025-05-22 | Replimune Group, Inc. (REPL) | Chief Executive Officer | Sell | 25,105 | $202,346 |
| 2025-04-03 | Replimune Group, Inc. (REPL) | Chief Executive Officer | Buy | 166,667 | $0 |
Source: SEC Form 4 filings · as of 2026-07-01